These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37294090)

  • 41. Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota.
    Tieu V; Tibi S; Ling J
    Front Cell Infect Microbiol; 2023; 13():1167827. PubMed ID: 37457959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.
    Galperine T; Choi Y; Pagani JL; Kritikos A; Papadimitriou-Olivgeris M; Méan M; Scherz V; Opota O; Greub G; Guery B; Bertelli C;
    BMC Infect Dis; 2023 Aug; 23(1):537. PubMed ID: 37596518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
    de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
    Front Immunol; 2021; 12():635471. PubMed ID: 33717181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
    Ahlawat S; Asha ; Sharma KK
    Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.
    Ahmadi Badi S; Tarashi S; Fateh A; Rohani P; Masotti A; Siadat SD
    Mediators Inflamm; 2021; 2021():6611222. PubMed ID: 33953641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients.
    Reinold J; Farahpour F; Schoerding AK; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Buer J; Witzke O; Westendorf AM; Kehrmann J
    Front Cell Infect Microbiol; 2022; 12():848650. PubMed ID: 35521219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
    Wang M; Zhang Y; Li C; Chang W; Zhang L
    Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional Foods: A Promising Strategy for Restoring Gut Microbiota Diversity Impacted by SARS-CoV-2 Variants.
    Banerjee A; Somasundaram I; Das D; Jain Manoj S; Banu H; Mitta Suresh P; Paul S; Bisgin A; Zhang H; Sun XF; Duttaroy AK; Pathak S
    Nutrients; 2023 Jun; 15(11):. PubMed ID: 37299594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the Pathogenicity of SARS-CoV-2 Delta and Omicron Variants by Analyzing the Expression Patterns of Immune Response Genes in K18-hACE2 Transgenic Mice.
    Kuruppuarachchi KAPP; Jang Y; Seo SH
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):316. PubMed ID: 36472114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing.
    O'Shea KM; Schuler CF; Chen J; Troost JP; Wong PT; Chen K; O'Shea DR; Peng W; Gherasim C; Manthei DM; Valdez R; Baldwin JL; Baker JR
    Front Immunol; 2023; 14():1055429. PubMed ID: 36845123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.
    Rochman ND; Faure G; Wolf YI; Freddolino PL; Zhang F; Koonin EV
    mBio; 2022 Apr; 13(2):e0013522. PubMed ID: 35289643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential implications of SARS-CoV-2 oral infection in the host microbiota.
    Xiang Z; Koo H; Chen Q; Zhou X; Liu Y; Simon-Soro A
    J Oral Microbiol; 2020 Nov; 13(1):1853451. PubMed ID: 33312449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
    Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of post-COVID symptoms of the SARS-CoV-2 Delta and Omicron variants in children: a prospective study.
    Yildirim Arslan S; Avcu G; Sahbudak Bal Z; Arslan A; Ozkinay FF; Kurugol Z
    Eur J Pediatr; 2023 Oct; 182(10):4565-4571. PubMed ID: 37526704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model.
    Pulit-Penaloza JA; Belser JA; Sun X; Pappas C; Brock N; Kieran TJ; Ritter JM; Seixas JN; Jones J; Basu Thakur P; Pusch E; Wang L; Tumpey TM; Wentworth DE; Zhou B; Maines TR
    mBio; 2022 Oct; 13(5):e0242122. PubMed ID: 36135377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbial and immune faecal determinants in infants hospitalized with COVID-19 reflect bifidobacterial dysbiosis and immature intestinal immunity.
    Gutiérrez-Díaz I; Sanz-Martinez M; Castro AM; Rodríguez-Belvís MV; Carreira N; Jiménez S; Mangas C; Queralt M; Herrador M; Martín-Masot R; Ferrer P; Navas-López VM; Espín B; Leis R; Díaz JJ; Delgado S
    Eur J Pediatr; 2023 Oct; 182(10):4633-4645. PubMed ID: 37555973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical implications of gut microbiota and cytokine responses in coronavirus disease prognosis.
    Seong H; Kim JH; Han YH; Seo HS; Hyun HJ; Yoon JG; Nham E; Noh JY; Cheong HJ; Kim WJ; Lim S; Song JY
    Front Immunol; 2023; 14():1079277. PubMed ID: 37051240
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant.
    Ren W; Zhang Y; Rao J; Wang Z; Lan J; Liu K; Zhang X; Hu X; Yang C; Zhong G; Zhang R; Wang X; Shan C; Ding Q
    mBio; 2023 Apr; 14(2):e0041623. PubMed ID: 37010428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.